Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook

血脂异常 医学 内科学 剩余风险 胆固醇 风险因素 代谢综合征 脂蛋白 内分泌学 糖尿病 甘油三酯 肥胖
作者
Vikrama Raja,Carlos Aguíar,Nasreen Al-Sayed,Yogeyaa S. Chibber,Hussein ElBadawi,M. Ezhov,Michel P. Hermans,Ramesh C. Pandey,Kausik K. Ray,Lâle Tokgözoğlu,Alberto Zambón,Jean-Pascal Berrou,Michel Farnier
出处
期刊:Atherosclerosis [Elsevier]
卷期号:383: 117312-117312 被引量:4
标识
DOI:10.1016/j.atherosclerosis.2023.117312
摘要

Dyslipidemia refers to unhealthy changes in blood lipid composition and is a risk factor for atherosclerotic cardiovascular diseases (ASCVD). Usually, low-density lipoprotein-cholesterol (LDL-C) is the primary goal for dyslipidemia management. However, non-high-density lipoprotein cholesterol (non-HDL-C) has gained attention as an alternative, reliable goal. It encompasses all plasma lipoproteins like LDL, triglyceride-rich lipoproteins (TRL), TRL-remnants, and lipoprotein a [Lp(a)] except high-density lipoproteins (HDL). In addition to LDL-C, several other constituents of non-HDL-C have been reported to be atherogenic, aiding the pathophysiology of atherosclerosis. They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. Therefore, non-HDL-C is now considered an independent risk factor or predictor for CVD. The popularity of non-HDL-C is attributed to its ease of estimation and non-dependency on fasting status. It is also better at predicting ASCVD risk in patients on statin therapy, and/or in those with obesity, diabetes, and metabolic disorders. In addition, large follow-up studies have reported that individuals with higher baseline non-HDL-C at a younger age (<45 years) were more prone to adverse CVD events at an older age, suggesting a predictive ability of non-HDL-C over the long term. Consequently, non-HDL-C is recommended as a secondary goal for dyslipidemia management by most international guidelines. Intriguingly, geographical patterns in recent epidemiological studies showed remarkably high non-HDL-C attributable mortality in high-risk countries. This review highlights the independent role of non-HDL-C in ASCVD pathogenesis and prognosis. In addition, the need for a country-specific approach to dyslipidemia management at the community/population level is discussed. Overall, non-HDL-C can become a co-primary or primary goal in dyslipidemia management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SOLOMON应助科研通管家采纳,获得10
刚刚
彭于晏应助科研通管家采纳,获得10
刚刚
英俊的铭应助科研通管家采纳,获得10
刚刚
传奇3应助科研通管家采纳,获得10
刚刚
SciGPT应助科研通管家采纳,获得10
刚刚
1秒前
Na完成签到 ,获得积分10
4秒前
Tang完成签到 ,获得积分10
4秒前
xzz完成签到,获得积分10
5秒前
zxm发布了新的文献求助10
5秒前
wangayting完成签到,获得积分10
9秒前
岩下松风完成签到,获得积分10
10秒前
10秒前
欣喜雪晴完成签到 ,获得积分10
11秒前
orixero应助zxm采纳,获得10
11秒前
大模型应助木光采纳,获得10
11秒前
宇宇子发布了新的文献求助10
13秒前
14秒前
16秒前
要开心发布了新的文献求助10
18秒前
隐形曼青应助俊逸红牛采纳,获得10
18秒前
19秒前
20秒前
小小王完成签到,获得积分20
22秒前
秀智发布了新的文献求助30
23秒前
丘比特应助xiaowang采纳,获得10
24秒前
桐桐应助要开心采纳,获得10
26秒前
科研通AI2S应助skysleeper采纳,获得10
26秒前
27秒前
丈八二桃发布了新的文献求助10
28秒前
lyris完成签到,获得积分20
29秒前
31秒前
laser13发布了新的文献求助80
32秒前
传奇3应助丈八二桃采纳,获得10
34秒前
35秒前
keyanxiaobai发布了新的文献求助10
35秒前
666JACS发布了新的文献求助10
37秒前
38秒前
40秒前
666JACS完成签到,获得积分10
44秒前
高分求助中
Thermodynamic data for steelmaking 3000
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Counseling With Immigrants, Refugees, and Their Families From Social Justice Perspectives pages 800
マンネンタケ科植物由来メロテルペノイド類の網羅的全合成/Collective Synthesis of Meroterpenoids Derived from Ganoderma Family 500
Electrochemistry 500
Broflanilide prolongs the development of fall armyworm Spodoptera frugiperda by regulating biosynthesis of juvenile hormone 400
Statistical Procedures for the Medical Device Industry 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2370444
求助须知:如何正确求助?哪些是违规求助? 2079143
关于积分的说明 5205728
捐赠科研通 1806334
什么是DOI,文献DOI怎么找? 901636
版权声明 558148
科研通“疑难数据库(出版商)”最低求助积分说明 481375